Boston Scientific has announced the global launch of the Expect 19 flex endoscopic ultrasound aspiration needle, used for acquiring tissue samples under endoscopic ultrasound (EUS) guidance for cancer diagnosis in organs adjacent to the gastrointestinal tract.

The Expect 19 flex needle features a Nitinol construction, providing improved flexibility compared to existing EUS-fine needle aspiration (FNA) devices, and a large diameter for expanded diagnostic capabilities.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

EUS is a non-surgical, less-invasive procedure that employs high-frequency sound waves to generate detailed images of the gastrointestinal tract and adjacent organs, including the pancreas, liver, bile duct and mediastinal space.

The Expect needle comprises an echogenic pattern enabling physicians to easily and accurately obtain a tissue sample while maintaining visibility during the procedure.

The echogenic pattern of the needle provides visibility and precise needle guidance within the targeted organ, and the cobalt chromium design will offer improved sharpness and pushability, along with deformation resistance, compared to traditional stainless steel needles.

See Also:

Shyam Varadarajulu, chief of endoscopy at University of Alabama at Birmingham, said: "The improved design of the Expect 19 flex needle allows for access to challenging anatomy and sampling of solid and cystic lesions where traditional needles of this size can’t be used."

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

"High-quality diagnostic samples are critical for accurately assessing malignancies and choosing the appropriate treatment path for patients," Varadarajulu added.

Boston Scientific Endoscopy Division president David Pierce said: "The Expect 19 flex needle provides physicians with a clinically differentiated product designed to help improve patient care."

"This important launch broadens our leading endoscopy portfolio and highlights our commitment to delivering advanced technologies to diagnose gastrointestinal diseases," Pierce added.

Boston Scientific is a developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties.